49 completed, 6 terminated, 4 unknown, 3 recruiting. 20 Phase 3, 19 Phase 2, 15 Phase 4, 7 Phase 1, 1 Early Phase 1.
Follow Cumberland Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Imaging Acetadote Metabolism in Glioblastoma Acetadote - Glioblastoma, GBM | Early Phase 1 | Recruiting | University of Texas Southwestern Medical Center | 10 | 2026-06-18 | 2026-06-23 |
| Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage Telavancin Injection - Subarachnoid Hemorrhage, Aneurysmal | Phase 4 | Recruiting | Aaron Cook | 20 | 2024-07-02 | 2025-12-26 |
| Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF) Ifetroban Sodium, Placebo - Idiopathic Pulmonary Fibrosis | Phase 2 | Recruiting | Cumberland Pharmaceuticals | 128 | 2024-01-31 | 2026-09-02 |
| Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy Ifetroban, Placebo - Duchenne Muscular Dystrophy Cardiomyopathy, Cardiomyopathy, Dilated | Phase 2 | Completed | Cumberland Pharmaceuticals | 46 | 2020-10-19 | 2026-03-17 |
| Thromboxane Receptor Antagonist to Improve Endothelial Function Ifetroban Sodium, Placebo - Cardiovascular Diseases, Vascular Dilation | Phase 2 | Completed | Jeffrey Rade | 57 | 2019-09-20 | 2024-12-05 |
| Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence Ifetroban Sodium, Placebo - Malignant Solid Tumor | Phase 2 | Unknown | Vanderbilt-Ingram Cancer Center | 30 | 2018-12-12 | 2024-06-27 |
| Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients Atorvastatin injection - Hypercholesterolemia, Dyslipidemias | Phase 2 | Completed | Cumberland Pharmaceuticals | 40 | 2018-08-07 | 2022-07-15 |
| Telavancin Pharmacokinetics in Cystic Fibrosis Patients Telavancin Injection - Cystic Fibrosis | Phase 4 | Completed | Joseph L. Kuti, PharmD | 18 | 2017-08-08 | 2019-10-24 |
| Safety and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients Ibuprofen - Pain, Fever | Phase 4 | Completed | Cumberland Pharmaceuticals | 30 | 2017-08-08 | 2020-11-20 |
| Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) Ifetroban Oral Capsule, Placebo Oral Capsule - Asthma, Aspirin-Induced | Phase 2 | Completed | Cumberland Pharmaceuticals | 54 | 2017-07-17 | 2024-07-10 |
| Study to Assess Safety and Efficacy of Ifetroban for Treatment of Portal Hypertension in Cirrhotic Patients Ifetroban, Placebo - Portal Hypertension, Liver Cirrhosis | Phase 2 | Completed | Cumberland Pharmaceuticals | 30 | 2017-03-06 | 2022-01-19 |
| Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension Oral Ifetroban, Oral Placebo - Scleroderma, Diffuse, Scleroderma, Systemic | Phase 2 | Active not recruiting | Cumberland Pharmaceuticals | 34 | 2017-01-01 | 2026-09-02 |
| Telavancin Pediatric PK Study (Ages >12 Months to 17 Years) Telavancin - Gram-Positive Bacterial Infections | Phase 1 | Terminated | Cumberland Pharmaceuticals | 22 | 2014-12-01 | 2024-06-24 |
| A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial Telavancin, Vancomycin, Daptomycin - Bacteremia | Phase 3 | Terminated | Cumberland Pharmaceuticals | 121 | 2014-12-01 | 2020-02-17 |
| Telavancin Observational Use Registry (TOUR) Vibativ - Hospital Acquired Bacterial Pneumonia, Complicated Skin and Skin Structure Infections | Completed | Cumberland Pharmaceuticals | 1063 | 2014-11-01 | 2019-01-15 | |
| Trial to Determine the Safety of Oral Ifetroban in Patients With a History of Aspirin Exacerbated Respiratory Disease Ifetroban, Oral Capsule, Placebo, Oral Capsule - Aspirin Exacerbated Respiratory Disease (AERD) | Phase 2 | Completed | Cumberland Pharmaceuticals | 19 | 2014-08-01 | 2017-05-15 |
| Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for Colonoscopy 90 grams of Crystalline Lactulose, 135 grams of Crystalline Lactulose, 180 grams of Crystalline Lactulose - Colonoscopy Preparation | Phase 2 | Completed | Cumberland Pharmaceuticals | 32 | 2014-04-01 | 2016-02-24 |
| Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery IV ibuprofen, Ketorolac - Pain | Phase 4 | Completed | Cumberland Pharmaceuticals | 100 | 2013-07-01 | 2016-03-14 |
| 2 Regimens of Lactulose for Colonoscopy Preparation in Adults Full dose preparation, Split dose preparation - Colonoscopy Preparation | Phase 2 | Completed | Cumberland Pharmaceuticals | 55 | 2013-07-01 | 2015-06-01 |
| Caldolor Versus Caldolor Plus OFIRMEV in Total Knee or Hip Arthroplasty Surgeries Ofirmev, Caldolor - Pain | Phase 4 | Completed | Anita Gupta | 78 | 2012-12-01 | 2016-02-29 |
Showing 20 of 65. Sign in to see all of them.
Hyponatremia (9) · Pain (7) · Fever (6) · Gram-Positive Bacterial Infections (4) · Burns (3) · Edema (3) · Kidney Diseases (3) · Staphylococcal Infections (3) · Abscess (2) · Asthma, Aspirin-Induced (2) · Cellulitis (2) · Hypertension, Portal (2) · Liver Cirrhosis (2) · Liver Diseases (2) · Pain, Postoperative (2)
Ibuprofen (16) · telavancin (14) · conivaptan (12) · Vancomycin (8) · ifetroban (7) · Saline Solution (5) · Acetaminophen (3) · Acetylcysteine (3) · Ketorolac (3) · Ketorolac Tromethamine (3) · Sodium Chloride (3) · Cloxacillin (2) · Lactulose (2) · Nafcillin (2) · Oxacillin (2)
United States (59) · India (6) · Israel (4) · South Africa (4) · Australia (3) · Spain (2) · Belgium (1) · Canada (1) · Colombia (1) · Finland (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Panama (1)
Art Wheeler, MD (13) · G. Ralph Corey, MD (7) · Art P Wheeler, M.D. (2) · Aaron M Cook, PharmD (1) · Adam Haberle, PhD (1) · Andrew White, MD (1) · Art P Wheeler, MD (1) · Art Wheeler, M.D. (1) · Arthur P Wheeler, MD (1) · Brendan McGuire, MD (1) · Don Rockey, MD (1) · Evan Brittain, MD (1) · Fernando L Arbona, MD (1) · Gordon Bernard, M.D. (1)
PMID 18444791, PMID 19095213, PMID 22416054, PMID 24708675, PMID 27718118, PMID 29454592, PMID 10770777, PMID 16436742, PMID 19843482, PMID 20591173, PMID 21542122, PMID 23570477, PMID 23769807, PMID 24884578, PMID 25592331, PMID 28143430, PMID 30338261, PMID 31685468, PMID 32372280, PMID 34041706, PMID 34048282, PMID 37294477, PMID 37815398